Thomas De Sutter

Ziekenhuis Oost-Limburg

Papers

2

Total Citations

2

H-Index

1

About

Thomas De Sutter is a pioneering surgeon whose work focuses on the frontiers of robot-assisted surgery for complex cardiovascular and urological conditions. His research is centered on developing and validating minimally invasive robotic techniques to treat therapy-resistant arterial hypertension and bladder cancer. In a landmark 2024 study, De Sutter introduced robot-assisted renal denervation as a novel surgical approach for patients with medication-refractory hypertension—a condition that leaves millions vulnerable to heart attack and stroke despite drug therapy. This work offers a new, precise intervention for a previously intractable problem. In 2025, he contributed a critical comparative analysis of stapled versus manually sutured bowel anastomosis during robot-assisted radical cystectomy (RARC), providing evidence to optimize surgical outcomes for muscle-invasive bladder cancer. While his most-cited papers are recent, their immediate impact signals a rising authority in robotic surgery. De Sutter’s contributions are notable for directly addressing high-stakes clinical challenges—treatment-resistant hypertension and cancer surgery—with innovative, minimally invasive solutions that promise to redefine standards of care.

Research Focus

Key Achievements

1
H-Index
2
Papers
2
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted renal denervation as a new surgical approach for therapy resistant arterial hypertension
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Ziekenhuis Oost-Limburg

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago